Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Proteins binding NKG2D, CD16 and CLEC12A

Proteins binding NKG2D, CD16 and CLEC12A

US Patent 12157771 · Granted Dec 3, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered SIRPα variants and methods of use thereof2025
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereo2025
Cancer therapy involving an anti-PD1 antibody and a multi-specific binding prote2025
Cancer therapy involving an anti-PD1 antibody and a multi-specific binding prote2025
Cancer therapy involving an anti-PD1 antibody and a multi-specific binding prote2025
Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of u2025
Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of u2025
Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of u2025
Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of u2025
Methods of treating cancer using multi-specific binding proteins that bind NKG2D2025
Proteins binding NKG2D, CD16 and a tumor-associated antigen2025
Proteins binding NKG2D, CD16 and a tumor-associated antigen2025